---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-061796"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2022-05-17T23:59:59+00:00"
generated_at: "2026-06-25T11:56:35.814670+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# VYNE hosts KOL event to update on BET inhibitor platform and VYN201

## Summary
- Virtual KOL event held May 17, 2022 on InhiBET platform and VYN201.
- Presentation attached as Exhibit 99.1 and available on company website.
- No specific clinical data or financial results disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-22-061796
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2022-05-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/0001104659-22-061796-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/tm2215701d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-061796
- JSON: https://secwatch.observer/filing/0001104659-22-061796.json
- Plain text: https://secwatch.observer/filing/0001104659-22-061796.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.